{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:10:49Z","timestamp":1772755849905,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":175,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CENTRO-01-0145-FEDER-030752"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-030752"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PD\/BDE\/150685\/2020"],"award-info":[{"award-number":["PD\/BDE\/150685\/2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["PD\/BDE\/150685\/2020"],"award-info":[{"award-number":["PD\/BDE\/150685\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neuropharm.2025.110441","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T16:18:54Z","timestamp":1743697134000},"page":"110441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Chronopharmacokinetics of the antidepressant paroxetine: An in vitro and in vivo approach"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-5458","authenticated-orcid":false,"given":"Soraia","family":"Silva","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-1671","authenticated-orcid":false,"given":"Joana","family":"Bicker","sequence":"additional","affiliation":[]},{"given":"Am\u00edlcar","family":"Falc\u00e3o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7490-0218","authenticated-orcid":false,"given":"Robert","family":"Dallmann","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-6639","authenticated-orcid":false,"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110441_bib1","unstructured":"ISO-10993-5:2009(E), Part 5: tests for in vitro cytotoxicity, in Biological Evaluation of Medical Devices. International Organization for Standardization. p. 34."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110441_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1503\/jpn.150205","article-title":"Why is depression more prevalent in women?","volume":"40","author":"Albert","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"issue":"7323","key":"10.1016\/j.neuropharm.2025.110441_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood\u2013brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110441_bib4","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43326","article-title":"Endocytosis at the Drosophila blood-brain barrier as a function for sleep","volume":"7","author":"Artiushin","year":"2018","journal-title":"Elife"},{"issue":"5488","key":"10.1016\/j.neuropharm.2025.110441_bib5","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1126\/science.289.5488.2344","article-title":"Resetting of circadian time in peripheral tissues by glucocorticoid signaling","volume":"289","author":"Balsalobre","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110441_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03190854","article-title":"Chronopharmacokinetic and bioequivalence studies of two formulations of trimipramine after oral administration in man","volume":"4","author":"Bougerolle","year":"1989","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110441_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.amjopharm.2012.01.001","article-title":"Age-related changes in antidepressant pharmacokinetics and potential drug-drug interactions: a comparison of evidence-based literature and package insert information","volume":"10","author":"Boyce","year":"2012","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.neuropharm.2025.110441_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuropharm.2015.12.009","article-title":"P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood-brain barrier in vivo","volume":"103","author":"Bundgaard","year":"2016","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110441_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0269881108089871","article-title":"Effect of antidepressants on melatonin metabolite in depressed patients","volume":"23","author":"Carvalho","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110441_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2147\/JPR.S176857","article-title":"Melatonin is a biomarker of circadian dysregulation and is correlated with major depression and fibromyalgia symptom severity","volume":"12","author":"Caumo","year":"2019","journal-title":"J. Pain Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110441_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tins.2019.05.001","article-title":"Regulation of the blood-brain barrier by circadian rhythms and sleep","volume":"42","author":"Cuddapah","year":"2019","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110441_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3184\/003685018X15306123582346","article-title":"Biologically-derived nanomaterials for targeted therapeutic delivery to the brain","volume":"101","author":"Curley","year":"2018","journal-title":"Sci. Prog."},{"key":"10.1016\/j.neuropharm.2025.110441_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105383","article-title":"The role of the circadian system in the etiology of depression","volume":"153","author":"de Leeuw","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110441_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2125.1986.tb02947.x","article-title":"Melatonin and cortisol increase after fluvoxamine","volume":"22","author":"Demisch","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110441_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2017.11.024","article-title":"Circadian clock-mediated regulation of blood pressure","volume":"119","author":"Douma","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110441_bib16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR\u2217D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110441_bib17","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1038\/s41598-017-07767-8","article-title":"Robust circadian clock oscillation and osmotic rhythms in inner medulla reflecting cortico-medullary osmotic gradient rhythm in rodent kidney","volume":"7","author":"Hara","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110441_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/j.2051-5545.2010.tb00298.x","article-title":"Pathophysiology of depression: do we have any solid evidence of interest to clinicians?","volume":"9","author":"Hasler","year":"2010","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110441_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/glia.23908","article-title":"Astrocytes are necessary for blood-brain barrier maintenance in the adult mouse brain","volume":"69","author":"Heithoff","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2025.110441_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol. Therapeut."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110441_bib21","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2025.110441_bib22","series-title":"ICH Harmonised Guideline","year":"2019"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110441_bib23","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1038\/s41380-023-02095-y","article-title":"A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression","volume":"28","author":"Jauhar","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110441_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41380-020-0843-0","article-title":"Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis","volume":"26","author":"Kato","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110441_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/07420528.2019.1624373","article-title":"Melatonin research in mice: a review","volume":"36","author":"Kennaway","year":"2019","journal-title":"Chronobiol. Int."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110441_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biopsych.2006.10.001","article-title":"Overweight and obesity affect treatment response in major depression","volume":"62","author":"Kloiber","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"D1","key":"10.1016\/j.neuropharm.2025.110441_bib27","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. l_6","key":"10.1016\/j.neuropharm.2025.110441_bib28","doi-asserted-by":"crossref","first-page":"vi8","DOI":"10.1093\/neuonc\/nou249.38","article-title":"P50DEVELOPING a physiologically relevant blood brain barrier model for the study of drug disposition in glioma","volume":"16","author":"Kumar","year":"2014","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110441_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41386-018-0156-z","article-title":"Sex differences in antidepressant efficacy","volume":"44","author":"LeGates","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110441_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/07420529109063924","article-title":"Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine","volume":"8","author":"Lemmer","year":"1991","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.neuropharm.2025.110441_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2015.03.007","article-title":"Diurnal and seasonal variation of the brain serotonin system in healthy male subjects","volume":"112","author":"Matheson","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2025.110441_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.sleep.2023.07.033","article-title":"Disruption of the circadian rhythm of melatonin: a biomarker of critical illness severity","volume":"110","author":"Melone","year":"2023","journal-title":"Sleep Med."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110441_bib33","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","article-title":"The serotonin theory of depression: a systematic umbrella review of the evidence","volume":"28","author":"Moncrieff","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"6381","key":"10.1016\/j.neuropharm.2025.110441_bib34","doi-asserted-by":"crossref","first-page":"eaao0318","DOI":"10.1126\/science.aao0318","article-title":"Diurnal transcriptome atlas of a primate across major neural and peripheral tissues","volume":"359","author":"Mure","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110441_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/07420529109063927","article-title":"Double-blind study of the chronopharmacotherapy of depression","volume":"8","author":"Nagayama","year":"1991","journal-title":"Chronobiol. Int."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110441_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/clpt.1983.61","article-title":"Chronopharmacology of amitriptyline","volume":"33","author":"Nakano","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"issue":"42","key":"10.1016\/j.neuropharm.2025.110441_bib37","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.1523\/JNEUROSCI.3639-16.2017","article-title":"Disruption of Bmal1 impairs blood-brain barrier integrity via pericyte dysfunction","volume":"37","author":"Nakazato","year":"2017","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110441_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.190","article-title":"Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression","volume":"3","author":"O'Brien","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110441_bib39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.113.089805","article-title":"Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice","volume":"85","author":"Oda","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110441_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46977-0","article-title":"Sex-, feeding-, and circadian time-dependency of P-glycoprotein expression and activity - implications for mechanistic pharmacokinetics modeling","volume":"9","author":"Okyar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110441_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0028-1094583","article-title":"Chronobiology and its implications for pharmacotherapy of endogenous depression","volume":"11","author":"Philipp","year":"1978","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110441_bib42","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archpsyc.65.9.1072","article-title":"Seasonal variation in human brain serotonin transporter binding","volume":"65","author":"Praschak-Rieder","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110441_bib43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.neuron.2020.09.002","article-title":"Neuronal activity regulates blood-brain barrier efflux transport through endothelial circadian genes","volume":"108","author":"Pulido","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110441_bib44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0006-8993(99)02462-2","article-title":"A 5-HT1B receptor agonist inhibits light-induced suppression of pineal melatonin production","volume":"858","author":"Rea","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110441_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110441_bib46","series-title":"Investigation into Circadian Rhythms within the Blood-Brain Barrier and Their Influence on Drug Permeability, in PhD Thesis","author":"Roberts","year":"2022"},{"key":"10.1016\/j.neuropharm.2025.110441_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1099-081X(199904)20:3<117::AID-BDD171>3.0.CO;2-V","article-title":"Chronopharmacokinetics of amitriptyline in rats","volume":"20","author":"Rutkowska","year":"1999","journal-title":"Biopharm Drug Dispos."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110441_bib48","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1208\/s12248-016-9973-3","article-title":"P-Glycoprotein function in the rodent brain displays a daily rhythm, a quantitative in vivo PET study","volume":"18","author":"Savolainen","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2025.110441_bib49","article-title":"Isolation and culture of mouse cortical astrocytes","volume":"71","author":"Schildge","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2025.110441_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0306-4530(99)00065-7","article-title":"Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers","volume":"25","author":"Schlosser","year":"2000","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110441_bib51","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3390\/pharmaceutics13111975","article-title":"Antidepressants and circadian rhythm: exploring their bidirectional interaction for the treatment of depression","volume":"13","author":"Silva","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2025.110441_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.751321","article-title":"Encapsulated escitalopram and paroxetine intranasal Co-administration: in vitro\/in vivo evaluation","volume":"12","author":"Silva","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110441_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116184","article-title":"Intranasal delivery of paroxetine: a preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences","volume":"223","author":"Silva","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110441_bib54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smrv.2016.02.003","article-title":"Circadian mechanisms of 24-hour blood pressure regulation and patterning","volume":"33","author":"Smolensky","year":"2017","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.neuropharm.2025.110441_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jpsychires.2018.11.009","article-title":"abcb1ab p-glycoprotein is involved in the uptake of the novel antidepressant vortioxetine into the brain of mice","volume":"109","author":"Spieler","year":"2019","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110441_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110441_bib57","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1152\/japplphysiol.00079.2011","article-title":"Light-dark oscillations in the lung transcriptome: implications for lung homeostasis, repair, metabolism, disease, and drug action","volume":"110","author":"Sukumaran","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110441_bib58","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0006-3223(03)00074-X","article-title":"Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption","volume":"54","author":"Uhr","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110441_bib59","unstructured":"Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110441_bib60","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41398-023-02614-z","article-title":"Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization","volume":"13","author":"Yao","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110441_bib61","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.7150\/thno.28676","article-title":"Small heterodimer partner regulates circadian cytochromes p450 and drug-induced hepatotoxicity","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110441_bib62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cell.2018.02.017","article-title":"A circadian clock in the blood-brain barrier regulates xenobiotic efflux","volume":"173","author":"Zhang","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110441_bib63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41467-020-20795-9","article-title":"A circadian clock regulates efflux by the blood-brain barrier in mice and human cells","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:34:04Z","timestamp":1769423644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825001479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":63,"alternative-id":["S0028390825001479"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110441","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronopharmacokinetics of the antidepressant paroxetine: An in vitro and in vivo approach","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110441"}}